First U.S. mesothelioma drug approved
Thursday March 25, 2004
The U.S. Food and Drug Administration (FDA) on February 4, 2004, approved Alimta (pemetrexed disodium) for use in combination with cisplatin for the treatment of patients with malignant pleural mesothelioma, Read More...